AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms
- 16 July 2004
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 321 (1), 161-167
- https://doi.org/10.1016/j.bbrc.2004.06.133
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Fatty acid synthase: A metabolic oncogene in prostate cancer?Journal of Cellular Biochemistry, 2003
- Management of cellular energy by the AMP‐activated protein kinase systemFEBS Letters, 2003
- AMP-activated protein kinase, super metabolic regulatorBiochemical Society Transactions, 2003
- Overexpression of fatty acid synthase is an early and common event in the development of prostate cancerInternational Journal of Cancer, 2001
- Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarrayBritish Journal of Cancer, 2001
- Selective activation of the fatty acid synthesis pathway in human prostate cancerInternational Journal of Cancer, 2000
- Fatty-acid synthase and human cancer: new perspectives on its role in tumor biologyNutrition, 2000
- Coordinate regulation of lipogenic gene expression by androgens: Evidence for a cascade mechanism involving sterol regulatory element binding proteinsProceedings of the National Academy of Sciences of the United States of America, 1997
- The AMP‐Activated Protein KinaseEuropean Journal of Biochemistry, 1997
- Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancerHuman Pathology, 1996